Luoxin Pharmaceuticals Group Stock Co., Ltd.

¥4.09As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002793Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (17.05%)
Div yield —
ROE (18.66%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.37
PE TTM —
TSR TTM (22.83%)
Mkt cap ¥4.448B
ROIC (8.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.31
29.93%
(82.16%)
Hold 2|10|10|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.09
0.09
0.09
3.00%
6.82%
6.87%
6.99%
Revenue¥M
249.8
256.5
255.3
250.6
8.82%
13.32%
7.07%
2.34%
Peers (US$666.8M)
Cap (US$)
PE
677.9M
13.74x
652.7M
139.3x
669.6M
3.849x
Capital
TTM
5Y
10Y
Leveragex
0.533
—
—
EBIT/Intx
2.795
0.167
0.176
Own earn%
14.86
(65.33)
(73.36)
Sh yield%
37.76
30.97
35.41
Owners
Insiders/Inst%
8.66
43.78
Short interest%
2.70
SBC / revenue%
5.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
10–13
$1 testx
0.0
Incr. ROIC%
40